Please login to the form below

Not currently logged in
Email:
Password:

Farmaindustria names Antoni Esteve as president

Will hold the position for the next two years

farmaindustria antoni esteveSpain's pharma trade body Farmaindustria has appointed Esteve's Antoni Esteve as its new president.

He will replace Elvira Sanz, president of Pfizer's Spanish operation, fulfilling the organisation's statute of alternating presidency between the head of domestic and foreign companies.

Esteve is president of Isdin, part of the his family's Esteve group that is based in Spain. He acknowledged that a key challenge will be ensuring quality patient access to innovative drugs and treatments at all times.

Esteve added over the next few years he will be “seeking new funding formulas and policies to ensure the sustainability of health systems so that they are compatible with the incorporation of the most advanced therapies.”

The decision was made during the Farmaindustria general assembly, which met in special session in Madrid and was opened by the Spanish minister for health, social services and quality, Ana Mato.

30th October 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics